How to Handle Overlapping Studies in an Umbrella Review

An umbrella review synthesizes findings across multiple existing systematic reviews, and this creates a specific, well-documented problem that doesn't arise in a standard systematic review of primary studies: the same primary study frequently appears in more than one of your included reviews, and if left unaddressed, this creates a form of hidden double-counting.

Why overlap happens

Systematic reviews on related topics often draw from the same pool of primary trials, particularly in well-studied clinical areas where a handful of large, influential trials get cited across many different reviews examining slightly different questions or outcomes. An umbrella review pulling together five related systematic reviews might find that one particular landmark trial appears in four of them.

Why this matters

If an umbrella review treats each included systematic review as an independent, equally weighted source of evidence without accounting for overlap, a single influential primary study effectively gets counted multiple times in the umbrella review's overall picture, giving it outsized influence on the conclusions without that influence being visible or disclosed anywhere in the reporting.

The Corrected Covered Area method

The Corrected Covered Area, commonly abbreviated CCA, is the most widely used method for quantifying overlap systematically. It compares the primary studies cited across your included systematic reviews and calculates a percentage reflecting how much overlap exists, typically classified into bands from slight to very high overlap. This gives you a concrete, reportable number rather than an impressionistic sense that "some of these reviews probably share studies."

What to do once you've measured overlap

Slight to moderate overlap is common and doesn't necessarily require a different analytical approach, though it should still be reported. High or very high overlap is a more serious concern, and options include restricting your umbrella review to the most comprehensive or highest-quality systematic review covering a given overlapping set of studies rather than including all of them, or presenting findings from overlapping reviews separately with the overlap explicitly flagged, rather than combining them as though they were independent.

Building a citation matrix

A practical way to actually see your overlap, not just calculate a summary statistic, is building a matrix with your included systematic reviews as columns and the primary studies they cite as rows, marking which primary studies appear in which reviews. This visual approach makes it immediately obvious which specific trials are driving overlap and lets you make an informed judgment about how to handle them, rather than relying on the CCA percentage alone.

Overlap and your umbrella review's conclusions

When writing up your umbrella review, it's worth stating explicitly which of your headline findings rest on largely independent bodies of evidence across your included reviews, versus which rest substantially on a small number of primary studies appearing repeatedly. This distinction matters directly for how much confidence a reader should place in different parts of your conclusions, and glossing over it understates a real limitation.

PRIOR reporting expectations

PRIOR, the reporting guideline specifically developed for umbrella reviews and overviews of reviews, expects explicit reporting of how overlap was assessed and managed, reflecting how central this issue is considered to umbrella review methodology specifically. An umbrella review submitted without any overlap assessment is missing an item a methods-aware reviewer will specifically look for.

A practical takeaway

Treating overlap assessment as a mandatory, early step in your umbrella review workflow -- run as soon as your systematic review inclusion list is finalized, before you move into synthesis -- prevents the more difficult situation of discovering significant overlap late in the process, after you've already built conclusions that may need to be revisited once the overlap is properly accounted for.

Software support for overlap calculation

Calculating the Corrected Covered Area by hand across a large citation matrix is genuinely tedious and error-prone once you have more than a handful of included reviews. Dedicated tools and R packages exist specifically to automate this calculation once you've built your citation matrix, reducing both the time cost and the risk of a manual counting error affecting your reported overlap statistic.

Overlap is a spectrum, not a pass-fail check

It's worth resisting the temptation to treat overlap as a binary problem to be eliminated entirely -- some degree of overlap across systematic reviews on a related topic is normal and expected, since well-conducted reviews on genuinely related questions will often, quite reasonably, draw on some of the same key trials. The goal of overlap assessment isn't to achieve zero overlap, which is rarely realistic, but to know how much overlap exists, understand which specific findings it might be inflating, and make an informed, disclosed decision about how to handle it rather than proceeding as though every included review contributes fully independent evidence.

Overlap assessment and your discussion section

Beyond the methods section reporting, your discussion should return to overlap when interpreting your headline findings, particularly noting explicitly if your most confident conclusion happens to rest heavily on a small, overlapping set of primary studies rather than broad, independent evidence across your included reviews. This connects your overlap assessment to how a reader should actually weigh your conclusions, rather than leaving it as an isolated methods-section statistic disconnected from your results. This connection between your methodology and your interpretation is ultimately what separates a genuinely rigorous umbrella review from one that merely reports an overlap number because it was expected. Readers evaluating your umbrella review's practical implications deserve to know not just that overlap exists somewhere in your evidence base, but specifically whether the conclusions they're most likely to act on are the ones resting on broad, independent evidence or the ones more vulnerable to a small set of repeatedly cited trials. Building this distinction into your discussion, even briefly, is a small addition that meaningfully improves how responsibly your umbrella review's findings are likely to be cited and acted upon by readers who may not otherwise think to check for it themselves. It's a small addition to your discussion section relative to the clarity it adds for anyone deciding how much weight to place on your review's conclusions.